Advances in Accurate Microbial Genome-Editing CRISPR Technologies

被引:12
|
作者
Lee, Ho Joung [1 ]
Lee, Sang Jun [1 ]
机构
[1] Chung Ang Univ, Dept Syst Biotechnol, Anseong 17546, South Korea
基金
新加坡国家研究基金会;
关键词
CRISPR; Cas9; genome editing; bacteria; mismatch intolerance; STRAND BREAK REPAIR; ESCHERICHIA-COLI; OFF-TARGET; CORYNEBACTERIUM-GLUTAMICUM; GUIDE RNA; IN-VITRO; DNA; CAS9; BASE; GENE;
D O I
10.4014/jmb.2106.06056
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previous studies have modified microbial genomes by introducing gene cassettes containing selectable markers and homologous DNA fragments. However, this requires several steps including homologous recombination and excision of unnecessary DNA regions, such as selectable markers from the modified genome. Further, genomic manipulation often leaves scars and traces that interfere with downstream iterative genome engineering. A decade ago, the CRISPR/Cas system (also known as the bacterial adaptive immune system) revolutionized genome editing technology. Among the various CRISPR nucleases of numerous bacteria and archaea, the Cas9 and Cas12a (Cpf1) systems have been largely adopted for genome editing in all living organisms due to their simplicity, as they consist of a single polypeptide nuclease with a target-recognizing RNA. However, accurate and fine-tuned genome editing remains challenging due to mismatch tolerance and protospacer adjacent motif (PAM)-dependent target recognition. Therefore, this review describes how to overcome the aforementioned hurdles, which especially affect genome editing in higher organisms. Additionally, the biological significance of CRISPR-mediated microbial genome editing is discussed, and future research and development directions are also proposed.
引用
收藏
页码:903 / 911
页数:9
相关论文
共 50 条
  • [1] Recent advances in CRISPR technologies for genome editing
    Song, Myeonghoon
    Koo, Taeyoung
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (06) : 537 - 552
  • [2] Recent advances in CRISPR technologies for genome editing
    Myeonghoon Song
    Taeyoung Koo
    Archives of Pharmacal Research, 2021, 44 : 537 - 552
  • [3] Perspectives of Genome-Editing Technologies for HIV Therapy
    Ebina, Hirotaka
    Gee, Peter
    Koyanagi, Yoshio
    CURRENT HIV RESEARCH, 2016, 14 (01) : 2 - 8
  • [4] Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools
    Long, Yicheng
    Cech, Thomas R.
    METHODS, 2021, 191 : 44 - 58
  • [5] Modulating CRISPR/Cas9 genome-editing activity by small molecules
    Chen, Siwei
    Chen, Deng
    Liu, Bin
    Haisma, Hidde J.
    DRUG DISCOVERY TODAY, 2022, 27 (04) : 951 - 966
  • [6] The commercialization of genome-editing technologies
    Brinegar, Katelyn
    Yetisen, Ali K.
    Choi, Sun
    Vallillo, Emily
    Ruiz-Esparza, Guillermo U.
    Prabhakar, Anand M.
    Khademhosseini, Ali
    Yun, Seok-Hyun
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2017, 37 (07) : 924 - 932
  • [7] Perspectives on the Application of Genome-Editing Technologies in Crop Breeding
    Hua, Kai
    Zhang, Jinshan
    Botella, Jose Ramon
    Ma, Changle
    Kong, Fanjiang
    Liu, Baohui
    Zhu, Jian-Kang
    MOLECULAR PLANT, 2019, 12 (08) : 1047 - 1059
  • [8] Inducible CRISPR genome-editing tool: classifications and future trends
    Dai, Xiaofeng
    Chen, Xiao
    Fang, Qiuwu
    Li, Jia
    Bai, Zhonghu
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2018, 38 (04) : 573 - 586
  • [9] Models of Technology Transfer for Genome-Editing Technologies
    Graff, Gregory D.
    Sherkow, Jacob S.
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020, 2020, 21 : 509 - 534
  • [10] Challenges and Advances in Genome Editing Technologies in Streptomyces
    Zhao, Yawei
    Li, Guoquan
    Chen, Yunliang
    Lu, Yinhua
    BIOMOLECULES, 2020, 10 (05)